×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
EBS – emergent biosolutions, inc. (US:NYSE)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
EBS
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
3/3
06:12 pm
ebs
Emergent Biosolutions (EBS) was downgraded by Weiss Ratings from "hold (c-)" to "sell (d+)".
Low
Report
Emergent Biosolutions (EBS) was downgraded by Weiss Ratings from "hold (c-)" to "sell (d+)".
3/3
08:13 am
ebs
Emergent BioSolutions Announces Appointment of John D. Fowler, Jr. to Board of Directors [Yahoo! Finance]
Low
Report
Emergent BioSolutions Announces Appointment of John D. Fowler, Jr. to Board of Directors [Yahoo! Finance]
3/3
08:00 am
ebs
Emergent BioSolutions Announces Appointment of John D. Fowler, Jr. to Board of Directors
Low
Report
Emergent BioSolutions Announces Appointment of John D. Fowler, Jr. to Board of Directors
2/28
01:18 am
ebs
Emergent Biosolutions Q4 Earnings Call Highlights [Yahoo! Finance]
Medium
Report
Emergent Biosolutions Q4 Earnings Call Highlights [Yahoo! Finance]
2/27
11:45 pm
ebs
Emergent BioSolutions Inc (EBS) Q4 2025 Earnings Call Highlights: Strategic Gains Amid Revenue ... [Yahoo! Finance]
Medium
Report
Emergent BioSolutions Inc (EBS) Q4 2025 Earnings Call Highlights: Strategic Gains Amid Revenue ... [Yahoo! Finance]
2/27
12:02 am
ebs
Emergent BioSolutions outlines $720M–$760M 2026 revenue target as transformation plan advances [Seeking Alpha]
Medium
Report
Emergent BioSolutions outlines $720M–$760M 2026 revenue target as transformation plan advances [Seeking Alpha]
2/26
04:22 pm
ebs
Emergent BioSolutions Announces New $50 Million Stock Repurchase Program [Yahoo! Finance]
High
Report
Emergent BioSolutions Announces New $50 Million Stock Repurchase Program [Yahoo! Finance]
2/26
04:05 pm
ebs
Emergent BioSolutions Reports Fourth Quarter and Full Year 2025 Financial Results
High
Report
Emergent BioSolutions Reports Fourth Quarter and Full Year 2025 Financial Results
Date
Time
Symbol
Company Name
Action
%Chg
10/29/2025
04:15 pm
EBS
emergent biosolutions, inc.
BEAT
Report
35.2%
emergent biosolutions, inc.
8/6/2025
04:15 pm
EBS
emergent biosolutions, inc.
BEAT
Report
32.5%
emergent biosolutions, inc.
5/7/2025
04:05 pm
EBS
emergent biosolutions, inc.
BEAT
Report
34.2%
emergent biosolutions, inc.
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
3/6
08:51 am
ebs
Form 4 Emergent BioSolutions For: May 07 Filed by: LINDAHL RICHARD S
Low
Report
Form 4 Emergent BioSolutions For: May 07 Filed by: LINDAHL RICHARD S
3/5
09:40 pm
ebs
Form 4 Emergent BioSolutions For: Mar 03 Filed by: PAPA JOSEPH C
Low
Report
Form 4 Emergent BioSolutions For: Mar 03 Filed by: PAPA JOSEPH C
3/5
09:38 pm
ebs
Form 3 Emergent BioSolutions For: Mar 01 Filed by: FOWLER JOHN D JR
Low
Report
Form 3 Emergent BioSolutions For: Mar 01 Filed by: FOWLER JOHN D JR
3/5
09:38 pm
ebs
Form 4 Emergent BioSolutions For: Mar 03 Filed by: FOWLER JOHN D JR
Low
Report
Form 4 Emergent BioSolutions For: Mar 03 Filed by: FOWLER JOHN D JR
3/5
09:21 pm
ebs
Form 4 Emergent BioSolutions For: Mar 03 Filed by: Lowry Simon C
Low
Report
Form 4 Emergent BioSolutions For: Mar 03 Filed by: Lowry Simon C
3/5
09:20 pm
ebs
Form 4 Emergent BioSolutions For: Mar 03 Filed by: Hartzel William
Low
Report
Form 4 Emergent BioSolutions For: Mar 03 Filed by: Hartzel William
3/5
09:20 pm
ebs
Form 4 Emergent BioSolutions For: Mar 03 Filed by: Perl Jessica
Low
Report
Form 4 Emergent BioSolutions For: Mar 03 Filed by: Perl Jessica
3/5
09:09 pm
ebs
Form 4 Emergent BioSolutions For: Mar 03 Filed by: Williams Paul Anthony
Low
Report
Form 4 Emergent BioSolutions For: Mar 03 Filed by: Williams Paul Anthony
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
8/30
Emergent BioSolutions (EBS) Investor Presentation - Slideshow [Seeking Alpha]
14.7%
9/4 Form 8-K Emergent BioSolutions For: Aug 30 10.7%
3/10 Here's Why Emergent Biosolutions, BioMarin, and Nuvasive Fell on Monday [The Motley Fool] 10.2%
3/4 Emergent BioSolutions Selects Axiom Fusion eClinical Suite as Its Global eClinical Suite 9.2%
5/1 Form 8-K/A Emergent BioSolutions For: Apr 30 8.9%
4/23 Emergent BioSolutions Signs Agreement to be U.S. Manufacturing Partner for Johnson & Johnson’s Lead Vaccine Candidate for COVID-19 8.5%
6/3 Emergent BioSolutions Awarded 10-Year HHS Contract Valued at Approximately $535 Million to Deliver Vaccinia Immune Globulin Intravenous (VIGIV) in Support of Smallpox Preparedness 8.2%
4/27 Emergent Biosolutions Inc (NYSE: EBS) had its "buy" rating re-affirmed by analysts at Chardan Capital. They now have a $71.00 price target on the stock. 7.2%
2/27 Form 4 Emergent BioSolutions For: Feb 25 Filed by: Strei Katherine 6.1%
3/11 Emergent BioSolutions Initiates Development of Plasma-Derived Product Candidates for the Treatment and Prevention of Coronavirus Disease 5.3%
9/4 Form 8-K Emergent BioSolutions For: Aug 30 10.7%
3/10 Here's Why Emergent Biosolutions, BioMarin, and Nuvasive Fell on Monday [The Motley Fool] 10.2%
3/4 Emergent BioSolutions Selects Axiom Fusion eClinical Suite as Its Global eClinical Suite 9.2%
5/1 Form 8-K/A Emergent BioSolutions For: Apr 30 8.9%
4/23 Emergent BioSolutions Signs Agreement to be U.S. Manufacturing Partner for Johnson & Johnson’s Lead Vaccine Candidate for COVID-19 8.5%
6/3 Emergent BioSolutions Awarded 10-Year HHS Contract Valued at Approximately $535 Million to Deliver Vaccinia Immune Globulin Intravenous (VIGIV) in Support of Smallpox Preparedness 8.2%
4/27 Emergent Biosolutions Inc (NYSE: EBS) had its "buy" rating re-affirmed by analysts at Chardan Capital. They now have a $71.00 price target on the stock. 7.2%
2/27 Form 4 Emergent BioSolutions For: Feb 25 Filed by: Strei Katherine 6.1%
3/11 Emergent BioSolutions Initiates Development of Plasma-Derived Product Candidates for the Treatment and Prevention of Coronavirus Disease 5.3%
TOP News Decliners
3/13
Why These Drug Stocks Soared Today [The Motley Fool]
-15.6%
3/6 Form 3/A Emergent BioSolutions For: Mar 05 Filed by: Kirk Sean -10.5%
11/7 Emergent Biosolutions Inc (NYSE: EBS) had its "hold" rating re-affirmed by analysts at Cowen Inc. They now have a $67.00 price target on the stock. -10.0%
3/10 Here's Why Emergent BioSolutions Jumped Higher on Tuesday [The Motley Fool] -9.3%
3/31 Emergent BioSolutions Signs Agreement with Novavax to Manufacture NanoFlu™ -6.1%
4/20 Form 4 Emergent BioSolutions For: Apr 16 Filed by: El-Hibri Fuad -5.7%
10/21 Emergent BioSolutions to Host 2019 Analyst & Investor Day -5.2%
9/10 Form 4 Emergent BioSolutions For: Sep 09 Filed by: Zoon Kathryn C -4.9%
3/2 Form 4 Emergent BioSolutions For: Feb 27 Filed by: Bailey Sue -4.6%
10/7 Here’s Why Emergent BioSolutions Stock Climbed 19.4% in September [The Motley Fool] -4.2%
3/6 Form 3/A Emergent BioSolutions For: Mar 05 Filed by: Kirk Sean -10.5%
11/7 Emergent Biosolutions Inc (NYSE: EBS) had its "hold" rating re-affirmed by analysts at Cowen Inc. They now have a $67.00 price target on the stock. -10.0%
3/10 Here's Why Emergent BioSolutions Jumped Higher on Tuesday [The Motley Fool] -9.3%
3/31 Emergent BioSolutions Signs Agreement with Novavax to Manufacture NanoFlu™ -6.1%
4/20 Form 4 Emergent BioSolutions For: Apr 16 Filed by: El-Hibri Fuad -5.7%
10/21 Emergent BioSolutions to Host 2019 Analyst & Investor Day -5.2%
9/10 Form 4 Emergent BioSolutions For: Sep 09 Filed by: Zoon Kathryn C -4.9%
3/2 Form 4 Emergent BioSolutions For: Feb 27 Filed by: Bailey Sue -4.6%
10/7 Here’s Why Emergent BioSolutions Stock Climbed 19.4% in September [The Motley Fool] -4.2%
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: